Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015515
Filing Date
2022-08-08
Accepted
2022-08-08 16:07:39
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20220630.htm   iXBRL 10-Q 2902849
2 EX-31.1 enta-ex31_1.htm EX-31.1 13635
3 EX-31.2 enta-ex31_2.htm EX-31.2 13626
4 EX-32.1 enta-ex32_1.htm EX-32.1 15630
5 GRAPHIC img215115768_0.jpg GRAPHIC 169126
  Complete submission text file 0000950170-22-015515.txt   9329218

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT enta-20220630_def.xml EX-101.DEF 123936
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT enta-20220630_cal.xml EX-101.CAL 45911
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20220630_lab.xml EX-101.LAB 342611
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20220630.xsd EX-101.SCH 36553
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20220630_pre.xml EX-101.PRE 268323
56 EXTRACTED XBRL INSTANCE DOCUMENT enta-20220630_htm.xml XML 1847395
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 221144385
SIC: 2834 Pharmaceutical Preparations